Screenshot 2024-03-04 161733

Empower your decision-making process with eQuantX’s comprehensive Health Economics services and solutions. We specialize in generating and disseminating real world evidence crucial for clinical,
regulatory, and commercial decision-making

null

SOLUTION

What we offer

Our customised models and analyses, including cost-benefit, cost-effectiveness, cost-utility, pharmacoeconomics, and health technology assessments, are designed to transform health meta-data and real-world evidence into actionable insights. With a focus on driving smarter decisions and meeting stakeholder needs with confidence, eQuantX ensures you navigate the complexities of healthcare with precision

null

IMPORTANCE

What is the purpose

HEOR studies play a pivotal role in shaping evidence-based healthcare practices, fostering
economic sustainability, and aligning pharmaceutical strategies with the broader healthcare landscape. This serves crucial purpose like

Economic
Impact Assessment

Evaluate the economic impact of healthcare interventions, including
pharmaceuticals, and involves assessing the cost-effectiveness, cost-benefit,and cost-utility of new treatments

Evidence
based Support

Provides evidence-based insights to support decision-making by healthcare stakeholders, including clinicians, payers, and policymakers. This aids in informed choices regarding treatment options, resource allocation, and healthcare policy development

Market
Access Strategies

Understanding the economic value and real-world outcomes of a product is essential for successful market penetration and reimbursement negotiations to develop robust market access strategies

Patient
Outcomes

Analysing real-world outcomes and patient-reported outcomes through HEOR studies focus on the patient perspective, and support in developing patient-centric healthcare solutions, enhancing treatment adherence, and improving overall patient outcomes

Strategic
Planning and Support

HEOR insights are very useful in strategic planning, ensuring that the pharma products align with healthcare priorities, demonstrate value, and meet the evolving
needs of the market

Value Assessment for Regulatory Submission

Providing valuable evidence for regulatory submissions, which give additional context on the broader impact of a drug, helping regulatory agencies assess its overall value beyond clinical efficacy

null

PROCESS

How we do it

In executing a Health Economics and Outcomes Research (HEOR) study, eQuantX starts with meticulous planning and design lay the groundwork, involving clear objective definition, literature review, and appropriate study design selection. Our data collection process emphasizing diverse sources and real-world evidence generation. Then we conduct economic and statistical analysis which applies robust techniques, including cost-effectiveness evaluation and sensitivity analysis
A patient-centric approach integrates patient-reported outcomes, capturing details like quality of life. Finally, our HEOR experts ensure effective communication and deliver strategic recommendations in accessible reports, presented in a user-friendly manner .This comprehensive framework ensures a systematic and insightful journey from research initiation to impactful stakeholder recommendations

ll Our Approach ll

1. Research Planning and Design

  1. Clearly define research objectives and questions
  2. Conduct a rigorous literature review to identify gaps and establish a foundation
  3. Choose an appropriate study design aligned with research goals

2. Data Collection and Management

  1. Identify and define relevant outcome measures for a holistic evaluation
  2. Gather diverse data sources, ensuring quality and relevance
  3. Implement strategies for real-world evidence generation, considering treatment patterns and adherence

3. Economic and Statistical Analysis

  1. Apply health economic analysis techniques (e.g., cost-effectiveness, cost-utility etc.)
  2. Utilize statistical methods for robust data analysis
  3. Conduct sensitivity analysis to assess parameter uncertainties

4. Patient-Centric Approach

  1. Integrate patient-reported outcomes for a comprehensive understanding
  2. Consider patient perspectives on quality of life, treatment satisfaction, and adherence

5. Communication and Recommendations

  1. Interpret study results in the context of research objectives
  2. Develop clear, accessible reports and presentations
  3. Provide strategic recommendations for stakeholders based on study outcomes
  4. Encourage continuous evaluation and adaptation of strategies based on emerging evidence and healthcare landscape changes

ll FEATURED ACTIVITIES ll

Patient-
Reported Outcomes
Integration

Enhances decision-making by incorporating patients’ firsthand experiences and perspectives, providing valuable insights into treatment effectiveness and overall health outcomes

Holistic
Quality of Life
Assessment

Employing utility assessment tools to quantify the perceived value or desirability of specific health states, aiding in the calculation of quality-adjusted life years (QALYs) ensuring a comprehensive understanding of the  impact of interventions

Meta-analysis and a Comprehensive Literature/Scientific Review

Rigorous evidence synthesis and a deep understanding of existing studies to inform strategic decision-making and optimize health outcomes

Performing
Markov Modeling

Defining relevant health states, assigning transition probabilities, determining time cycles, and incorporating costs and utilities, allows for a comprehensive assessment of the long-term impact of healthcare interventions

Expert
HEOR Analysis

Our expert HEOR analysis offers cost-effectiveness modeling, budget impact analysis, and real-world evidence synthesis for a comprehensive understanding of economic implications, healthcare resource utilization, and the practical outcomes associated with their products

Real-world
Evidence Utilization

HEOR insights are very useful in strategic planning, ensuring that the pharma products align with healthcare priorities, demonstrate value, and meet the evolving needs of the market

Disease
Burden Analysis

Comprehensive evaluation of the societal and economic impact of health conditions, includes assessing morbidity, mortality, quality of life, and associated costs, providing valuable insights for healthcare resource allocation and policy development

Effective
Communication

Facilitating publication support by providing comprehensive assistance in manuscript development, journal selection, and submission processes, ensuring the effective communication of valuable health economic and outcomes research insights


ll FEATURED PRODUCTS ll

PayerPro360
(Quick Payer Research)

null

ADVANTAGE

What Differentiates Us

1971503 (1)

Integrates rigorous data analytics, real-world evidence, and economic evaluations

3222498

Prioritizing
patient-centricity

technology

Solving
difficult value changes

1924454

Web and mobile based
health economics models

Data Analysis

Social media listening and
insights generation

pngtree-risk-management-line-icon-vector-png-image_6639910

Interactive data visualizations
of complex data sets

null

ACCOMPLISHMENT

Impact by numbers

0
+
Independently developed economic and population health models in support of the value proposition across all phases of the product’s lifecycle
0
+
Collaboration with US Payer, Market Access, and Medical Science Liaison field-based teams to understand and meet needs of key partner evidentiary requirements
0
m+
de-identified, EHR-
sourced data scanned and
analyzed for
conducting deep retrospective research studies
0
+
Completed HEOR studies including cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis and health technology assessment
0
+
Scientific team member
regularly contributes articles to
trade and peer-reviewed
publications
0
+
key therapeutic areas
RWD studies experience
to produce regulatory
grade analysis
0
+
Markets experience / knowledge ofglobal HTAs evidentiaryrequirements and processes
0
+
of years’ experience in technical and analytic capabilities in real world evidence, economic modeling, economic evaluation, cost-effectiveness evaluation, and patient focused outcomes
0
+
Customized value & evidence platform created to identify, demonstrate and communicate product value
null

SUCCESS STORIES

Case Studies

Development of Budget Impact Analysis Model, Health Economics & Outcome Research

Development of a Local Economic Model: Cost-of-Illness (COI)/ Burden of Disease (BOD) Analysis